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Abstract A Kex2-1ike protease was identified in hemocytes of 
the horseshoe crab (Tachypleus tridentatus), named limulos 
kexin, and a full-length cDNA was obtained from a hemocyte 
cDNA library. The deduced amino acid sequence contains 752 
residues, composed of five domains with a signal sequence, a 
propeptide, a catalytic domain, a SerfFhr-rich domain, and a 
transmembrane domain. The domain organization is very similar 
to that of the yeast Kex2 except hat limulus kexin does not have 
a cytoplasmic tail. The catalytic domain exhibits striking 
sequence identities with those of furins, especially Drosophila 
furinl (79%). Northern blotting showed specific expression of 
limulus kexin in hemocytes, suggesting the involvement in 
proteolytic processing of the granule components of hemocytes. 
Key words: Kex2-1ike protease; Subtilisin-like proprotein 
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2. Materials and methods 
2.1. Polymerase chain reaction (PCR) and cDNA cloning of limulus 
kexin 
To amplify first-strand cDNA prepared from the poly(A) + RNA of 
horseshoe crab hemocytes by PCR, two degenerate oligonucleotide 
primers corresponding to amino acid sequences (-HGTRCA- for the 
sense primer and -TWRDMQ- for the antisense primer) of the cata- 
lytic domain conserved among the members of the kexin family were 
designed. PCR was performed in a Perkin Elmer Cetus thermal cycler 
for 60 cycles of denaturation (94°C, 1 min), annealing (40°C, 1 min), 
and extension (65°C, 1.5 min). The resulting PCR product of 0.6 kb 
was subcloned into pBluescript II SK + (Stratagene) and used as a 
probe for screening. Plaque hybridization experiments and nucleotide 
sequence analysis were performed as previously described [11]. One 
positive clone with a 2.6-kb insert was subcloned into the EcoRI site 
of pBluescript II SK + and the nucleotide sequence was determined on 
both strands. 
1. Introduction 
A number of Kex2-1ike proteases (kexin family) with differ- 
ent substrate specificities are present beyond species in eukar- 
yotes such as mammals [1-3], insects [4-6], mollusks [7], cni- 
darians [8], and protochordates [9]. They are Ca2+-dependent 
serine proteases with a bacterial subtilisin-like catalytic do- 
main and responsible for proteolytic processing of proproteins 
at dibasic sites. The hemolymph circulating in chelicerata 
horseshoe crab contains granular hemocytes comprising 99% 
of the total hemocytes, highly sensitive to bacterial endotox- 
ins, lipopolysaccharides [10]. The granular hemocytes tore 
granular specific proteins into two types of granules, large 
and small granules, which are released in response to external 
stimuli such as lipopolysaccharides and Ca2+-ionophore [11- 
13]. The granular components, which include serine protease 
zymogens and protease inhibitors participating in hemolymph 
coagulation, lectin-like proteins, and antimicrobial substances 
[14-18], have been characterized and cloned. The cDNA se- 
quence analyses indicate that some of them are synthesized as 
preproproteins with an NHz-terminal propeptide, in addition 
to a signal sequence, which linked to their mature proteins 
through an -Arg-X-Arg/Lys-Arg- motif, suggesting the pres- 
ence of Kex2-1ike proteases. We report here the identification 
of a new kexin-like protease, named limulus kexin, that is 
expressed specifically in horseshoe crab hemocytes. 
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2.2. Northern blotting 
Total RNAs were prepared from the various tissues by the acid 
guanidinium thiocyanate-phenol-chloroform method [19] and the 
poly(A) + RNAs were purified using Oligotex-dT30<Super> (Takara 
Shuzo Co., Kyoto). Northern blot analysis was performed using a 
digoxigenin-containing cRNA probe prepared from the horseshoe 
crab eDNA subcloned inpBluescript II SK + using T7 RNA polymer- 
ase and digoxigenin-I I UTP, as described previously [11]. 
3. Results 
3.1. cDNA cloning and sequence analysis 
The PCR using the degenerate oligonucleotide primers 
based on the conserved amino acid sequences in the catalytic 
domain of the kexin family yielded a band of about 600 bp, 
which is consistent with the distance between the sequences, 
and the product was subcloned for further analysis. Sequence 
analysis revealed that the DNA with 603 bp (designated Pcat) 
has the significant sequence similarity with the corresponding 
catalytic domain of Kex2-1ike proteases. To isolate the full- 
length clone, a hemocyte cDNA library was screened, using 
Pcat as a probe. Eleven positive plaques were obtained by 
screening 5 x 105 phages and the cDNA with the longest insert 
was sequenced. It contained 2558 bp starting with the ATG 
codon at nucleotide position 95 and had an open reading 
frame of 2256 bp (Fig. 1). The open reading frame encoded 
752 amino acid residues of a preproprotein containing a sub- 
tilisin-like catalytic domain from Asn 126 to Ala 413 homologous 
to the kexin family, indicating that the eDNA codes for a 
Kex2-1ike protease of horseshoe crab (designated limulus kex- 
in). A putative signal sequence of 27 residues with a typical 
hydrophobic core [20] and cleavage at Argl12-Asp na with an 
-Arg-X-Lys-Arg-motif could yield a mature protein of 640 
residues with a calculated Mr=71 040. There are 10 N-linked 
sugar potential sites in the proprotein. Judging from the se- 
quence similarity with subtilisin BPN' [21], functionally im- 
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CGAGGATCCGGGTACCATGGGTTTACTGAAACTTATTTTT GTTTAATT TT ATTTGC ATCC ATTAATTTTGCAATACGTT TCCG ATTTTTGTGGAATGGCAT CGAACTGT AGAATATTCAG 120 
* M A S N C R I F S 9 
TATT AACTCTAC AAAATT ATTGCTTTTACAATGTTTTTTTACATTATT GAGC ACGTTATT AGCG AATAAT TCGCACT ACACAGACCAGTTT GTTGTTCGCGTCGAGGGT GGCC CAAAAGT 240 
I N S T K L L L L Q C F F T L L S TAL  L A N N S H Y T D Q F V V R V E G G P K V 49 
CGCCAAAGAATTAGCAGAAAAACATGGATTTGTTTATTTAGGAGAG AT ATTTGACAAT TATC ATCACCTC AGACATCACCAAGTGTCGAAACGCTCAATAG ACC TAGC CTTCGCCACC A 360 
A K E L A E K H G F V Y L G E I F D N Y H H L R H H Q V S K R S I E P S L R H H 89 
CGAAGC ACTTCATTCAGATAAACAGGTGAAATGGTTTT CTCAACAG ACCCTGAAAAAGCGAT CGAAGCGTGATTT GTCATATTTTTACACGGACACT GTTC CGTA TTTG AATGATCCCAA 480 
E A L H S D K Q V K W F S Q Q T L K K R S K R~D L S Y F Y T D T V P Y L N D P K 129 
GTGGAAGGATATGTGGTATCTGAATAGAGGAAATAACCTA GATATG AATGTT AAACCAGCGTGGGATATGAAAGT A CTGGAAAAGGTGTGGTGGTC ACTATACTG~C GATGGACTAGA 600 
W K D M W Y L N R G N N L D M N V K P A W D M K V S G K G V V V T I L ~ D G L E 169 
AAAGGATCATCCAGATAT CAAAGAAAACTATGATCCTAAAGC GAGCTATG ACGTAAACAACAATGATGACGAC CCGC AACCTC GATACGATATTATT AACTCAAATAGGrC~CGGAAC CAG 720 
K D H P D I K E N Y D P K A S Y D V N N N D D D P Q P R Y D I I N S N R ~)  G T R 209 
ATGTGCTGGTGAAGTTGCTGCGATAGCGAACAACAGTATCTGTGCTGT CGGCATTGCT TTTCATGCTGGAATTGG AGGTGTTCGGATGCTGGATGGAGA TGTTAC TGATGCTGTTGAGGC 840 
C A G E V A A I A N N S I C A V G I A F H A G I G G V R M L D G D V T D A V E A 249 
TCGGTCGTTGAGTTTAAATTCACAATATATAGACATCT ACAGTGCCTC TTGGGGTC CCGACGATGATGGGAGGAC CGTGGATGGGCCTGGAGAGCTTGC AACTGAAGCATTTATTCATGG 960 
R S L S L N S Q Y I D I Y S A S W G P D D D G R T V D G P G E L A T E A F I H G 289 
~G~AG~TCGAAA~~TATTTGTTTGGGCTTCTGGT~TGGT~GA~TAATGAT~CTGT~GTGATGGCTATACT~CTCCAT~GGAC~TGTCCAT 1080 
I E K G R N G L G S I F V W A S G L ~ G G R N N D N C N C D G Y T N S I W T L S I  329 
TAGT~TGCCACAGAG~GA~CCAT~TATA~GAGGCCTGCT~TTCTTCTTTAGCT~CATATAGTAGT~ATCA~CGGAGAAAGGGA~ATCACGTCTGATTTGCA 1200 
S S A T E N G L V P W Y S E A C S S S L A A T Y S S G S G G E R E I I T S D L H  369 
CCAT~GTACTACACAA~ACAC~AC~A~TTCTGCTCCTTT~CTGCTGGAAT~GT~ACTT~ACTTG~GCT~CAAAC~TACTTGGAG~GACATGCAACACATAGT 1320 
HSCTTQHTGT~ASAPLAAGICALALEANKQLTWRDMQHIV  409 
~TTAG~G~TCGA~AG~TACAGTC~GTGATTGGAAGA~TAATGGTGTAGG~GACATGTCAGT~ACTCATTTG~TATGGA~TGGATG~TG~AGCAATGGTG~GTT 1440 
V R T A R L A N L Q S S D W K T N G V G R H V S H S F G Y G V M D A A A M V K L  449 
~CA~AGTC~G~GA~AG~C~AA~CAG~ACTGTCTATGCTGACATCAT~AC~GATAATTTCTCCA~CTcACATTGAAGTTA~TCTGAGTGTT~ATTGTTCGAA 1560 
A K V W K T V P K Q K V C T V Y A D I M D K I I S P K T H I E V T L S V H C S K  489 
~TG~T~AG~CATGTACA~CAGATCACAC~TCTTCAACTAGAAGAGGTGACATCCACATTTATCTGATATCTCC~T~AC~AAGTCCA~CTTCTAGA~GACGACC 1680 
V K F L E H V Q A Q I T L S S T R R G D I H I Y L I S P M G T K S T L L E R R P  529 
ACTTGACACCTATCGTTCAG~TGTA~TT~CCATTCCTTACTGTCCAC~CT~GGTG~GTCCCGATGGAG~TGGAAGCTAGAGATTCAT~TG~ACGCTTTTTTGGTCG 1800 
L D T Y R S G F V N W P F L T V H N W G E S P D G E W K L E I H N E G R F F G R  569 
TGCTTCACTTACC~CTG~C~TGA~GTAT~TACCTCAGAGGATCCACAACCATT~AG~T~ACATAGATC~TAG~TATTCCATACC~CA~TTTTGCTTAC~G~ 1920 
A S L T N W T M I L Y G T S E D P Q P L Q K N K H R S L E Y S I P T N F A Y K N  609 
CTC~A~C~GACTA~CC~C~CCACTACTGT~CTGA~AGTAcTA~cGA~TG~GATAT~TACTGG~GAAAATTTC~TGATAG~ATT~TTAT~AT 2040 
S T S N K T T S T F P T T V T E T V L P S T E D I I L L E E N F N D S I N Y N I  649 
CA~AG~CCGA~ATGAC~C~CA~ATC~CTATAACTCCATGTTCTTTCCTGGTAT~GTCAATCAGACTACA~TA~CG~TAAACA~GCGA~AGGAATCAGAGTT 2160 
S S S D Y D N N S I N Y N S M F F P G M S Q S D Y K Y S G V N S A R K K E S E F  689 
O 
TG~AGT~TAGAAA~TA~A~C~TGACAT~AT~AT~TGTTTCATCAGTATCCTG~ATAAG~T~G~C~GT~TAGA~CC~T~TAG~G 2280 
V D S F R N V S T S N S D M G M H P V S S V S W D K V F K N V E V I E A N N S C  729 
CA~CATCAGTAGATGTATA~~CT~TGCTCTTCTCTATATG~GGATG~TACTTTGT~L~.CATACCACTCACCA~GATCAGATTTTAGTCTCTGCTC~T 2400 
T A I S R C I F L W C L L L F S I W W M N T L *  752 
CT~ACCCTTTG~TCAT~CT~ATTGCATGTG~AGTT~GGAC~cC~ATTAT~CATT~T~CTGTAATAGTA~AC~CTTAT~TTTATTATTGTGCC~AAATA 2520 
T T T C ~ T C T T ~ T A C A ~ T ~  2558 
Fig. I. Nuc leot ide  and  deduced amino  acid sequences  of  l imulus kexin. Putative c leavage sites ~r  the signal peptide and  propept ide  are indi- 
cated by open and closed triangles, respectively. Potential N-glycosylation sites are indicated by closed circles. The active sites Asp, His, and 
Ser residues are circled, and the Asn residue involved in the oxyanion hole is boxed. The putative transmembrane se~ent  (a double line), the 
Ser-T~-Gly sequen~ (a solid line), and the Arg-Gly-Asp sequence (a dotted line) are also indicated. 
portant amino acid residues such as Asp 16~, His 2°6 and Ser as° 
for the catalytic triad, and Asn a°7 participated in the forma- 
tion of the oxyanion hole, and -Ser26~-Trp266-Gly267- for a 
substrate binding site were well conserved. Another notable 
structural feature, a potential integrin-binding sequence of 
-ArgS°7-GlyS°8-Asp~°9- with unknown function in the kexin 
family, was also conserved at the corresponding positions. 
Furthermore, there was a domain (Ser 61° to Ser 712) highly 
occupied by Ser and Thr residues, accounting for 31% in 
this region. The hydropathy profile indicated that a hydro- 
phobic region is located at the COOH-terminal part from 
Ile 7a6 to Leu 752, in addition to the NH~-terminal signal se- 
quence, suggesting the presence of a transmembrane domain. 
3.2. Tissue specific expression of  limulus kexin 
To determine the size of the mRNA and to investigate 
tissue specific expression of limulus kexin, Northern blot ana- 
lysis was performed using poly(A) + RNAs prepared from 
hemocytes, heart, hepatopancreas, stomach, intestine, and 
skeletal muscle (Fig. 2). The expression of limulus kexin was 
only detected in hemocytes with three different sizes of tran- 
scripts, 3.4 kb, 6.4 kb and 7.7 kb, but any sizes of the tran- 
scripts were not detectable in other tissues. 
4. Discussion 
We have found the presence of a Kex2-1ike protease in 
horseshoe crab hemocytes and determined the cDNA se- 
quence. The deduced amino acid sequence clearly shows the 
protein to be a member of the kexin family. Limulus kexin is 
composed of at least five domains with a signal sequence, a
propeptide, a subtilisin-like catalytic domain, a Ser/Thr-rich 
domain, and a hydrophobic transmembrane domain, as sche- 
matically shown in Fig. 3. The domain organization is very 
similar to that of the yeast Kex2 protease. The catalytic do- 
main of limulus kexin from Asn 126 to Ala 413 exhibits striking 
sequence identities with those of furins, in which Drosophila 
furinl has the highest homology (79% identity). Limulus kex- 
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in, however, has lower sequence homology to those of PC2 
and PC1/3, suggesting that it is more structurally related to 
the furin subfamily than PCs. A Ser/Thr-rich domain, which 
does not exist in other members of the kexin family except for 
the yeast Kex2 protease, is noticed. In furins and PACE4, this 
domain is replaced by a cysteine-rich domain [1-3]. Recently, 
a Ser/Thr-rich segment composed of about 20 amino acid 
residues was found in Aplysia PC1A [7] and Aplysia furin2 
[22]. The Ser/Thr-rich domain of Kex2 is thought o have O- 
linked oligosaccharide chains [23]. Furthermore, 50% of N- 
linked sugar potential sites are also localized in the domain 
of limulus kexin, suggesting that this domain is highly glyco- 
sylated. Limulus kexin has a hydrophobic segment at the 
COOH-terminal portion and therefore it may bind to a mem- 
brane. It is noteworthy that limulus kexin does not have a 
cytoplasmic tail unlike the yeast Kex2 protease and furins. 
Since the cytoplasmic tail of mammalian furins is known to 
play an important role in their localization at the trans-Golgi 
[24,25], the subcellular localization of limulus kexin may differ 
from those of furins. 
The expression of mRNA of limulus kexin was detected 
only in hemocytes (Fig. 2). PC1/3, PC2, and PC4 are also 
expressed in limited tissues and are responsible for proteolytic 
processing of proproteins stored in granules through a regu- 
lated secretory pathway [1-3]. On the other hand, furins are 
expressed in almost all tissues and such broad tissue expres- 
sion indicates that furins participate in processing constitu- 
tively secreted proteins [1-3]. However, Nagle et al. have sug- 
gested that Aplysia furin2, a furin-like convertase, is present in 
secretory granules to process egg-laying hormone-related pre- 
cursors [22]. Therefore, the limited expression of limulus kexin 
supports the notion that this protease is involved in the pro- 
cessing of the granular components of the hemocytes through 
the regulated secretory pathway. 
The molecular basis for differences among the three tran- 
scripts with the sizes of 7.7 kb, 6.4 kb, and 3.4 kb is currently 
unknown. They may be generated by alternative RNA splic- 
ing of the same primary transcript or they may be products 
from distinct genes encoding isoforms. The PCR product 
(Pcat) obtained by amplifying the catalytic region coded for 
a slightly different sequence from the cloned enzyme (95°/'0 
123456 
7.7kb: .- 
6.4kb:  
3.4kb)"  
Fig. 2. Northern blot analysis of limulus kexin. Poly(A) + RNAs (1 
ktg) prepared from various tissues of horseshoe crab were analyzed 
using the cRNA probe. Lane 1, hemocytes; lane 2, heart; lane 3, 
hepatopancreas; lane 4, stomach; lane 5, intestine; lane 6, skeletal 
muscle. 
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SP PP SCD S/TRD TMD 
Llmulus kexln ~ -"~-~- I 752 residues 
dFu,n ~ I " 
.F.,,n ~ : ,0~ 
CRD 
mFurln ~ ~ : 793 
hPAeE4 ~ ~ . 9  
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Fig. 3. Domain organization of members of the kexin family. The 
percentages indicate the sequence identities between the catalytic do- 
mains of each protease and horseshoe cab kexin. SP, signal peptide; 
PP, propeptide; SCD, subtilisin-like catalytic domain; S/TRD, Ser/ 
Thr-rich domain; TMD, transmembrane domain; CRD; Cys-rich 
domain, dFurin, Drosophila furinl [4]; aFurin, Aplysia furin [7]; 
mFurin, mouse furin [26]; hPACE4, human PACE4 [27]; aFurin2, 
Aplysia furin2 [23]; mPC6, mouse PC6 [28]; mPC4, mouse PC4 
[29]; mPC3, mouse PC3 [30]; mPC2, mouse PC2 [31]; Kex2, yeast 
Kex2 [32]. 
amino acid sequence identity, data not shown), indicating 
the existence of at least one more Kex2-1ike protease in the 
hemocytes. The yeast has only one proprotein convertase, 
Kex2, whereas cnidarian Hydra, the most simple organism 
possessing specialized tissues, has two isoforms of PCl/3-1ike 
protease [8], and in mollusk Aplysia, five members of the 
kexin family including PC2- and furin-like enzymes have 
also been identified [7,22]. Thus, further studies will be re- 
quired to elucidate a functional role of limulus kexins in 
horseshoe crab. 
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